These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9660700)

  • 1. How anthrax kills.
    Hanna P
    Science; 1998 Jun; 280(5370):1671, 1673-4. PubMed ID: 9660700
    [No Abstract]   [Full Text] [Related]  

  • 2. New clue to how anthrax kills.
    Strauss E
    Science; 1998 May; 280(5364):676. PubMed ID: 9599144
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular pathogenesis of Bacillus anthracis infection.
    Little SF; Ivins BE
    Microbes Infect; 1999 Feb; 1(2):131-9. PubMed ID: 10594977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
    Vitale G; Pellizzari R; Recchi C; Napolitani G; Mock M; Montecucco C
    Biochem Biophys Res Commun; 1998 Jul; 248(3):706-11. PubMed ID: 9703991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax pathogenesis and host response.
    Hanna P
    Curr Top Microbiol Immunol; 1998; 225():13-35. PubMed ID: 9386326
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin.
    Moayeri M; Robinson TM; Leppla SH; Karginov VA
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2239-41. PubMed ID: 18378717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited.
    Tonello F; Ascenzi P; Montecucco C
    J Biol Chem; 2003 Oct; 278(41):40075-8. PubMed ID: 12888555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax X-rayed: new opportunities for biodefence.
    Stubbs MT
    Trends Pharmacol Sci; 2002 Dec; 23(12):539-41. PubMed ID: 12457764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin.
    Bromberg-White J; Lee CS; Duesbery N
    Toxins (Basel); 2010 May; 2(5):1038-53. PubMed ID: 22069624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular mechanisms underlying bacillus anthracis infection at early stages and search for novel vaccines].
    Stepanov AV; Marinin LI; Staritsyn NA; Noskov AN; Borovkova LV; Kravchenko TB
    Vestn Ross Akad Med Nauk; 1997; (6):16-20. PubMed ID: 9289272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide.
    Dang O; Navarro L; Anderson K; David M
    J Immunol; 2004 Jan; 172(2):747-51. PubMed ID: 14707042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthrax: virulence and vaccines.
    Farrar WE
    Ann Intern Med; 1994 Sep; 121(5):379-80. PubMed ID: 8042830
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
    Cote CK; Welkos SL
    Toxins (Basel); 2015 Aug; 7(8):3167-78. PubMed ID: 26287244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quickening the pace of anthrax research: three advances point towards possible therapies.
    Chaudry GJ; Moayeri M; Liu S; Leppla SH
    Trends Microbiol; 2002 Feb; 10(2):58-62. PubMed ID: 11827799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.
    Agrawal A; Lingappa J; Leppla SH; Agrawal S; Jabbar A; Quinn C; Pulendran B
    Nature; 2003 Jul; 424(6946):329-34. PubMed ID: 12867985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthrax toxins and the host: a story of intimacy.
    Mock M; Mignot T
    Cell Microbiol; 2003 Jan; 5(1):15-23. PubMed ID: 12542467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase.
    Koo HM; VanBrocklin M; McWilliams MJ; Leppla SH; Duesbery NS; Vande Woude GF
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3052-7. PubMed ID: 11867750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small molecule inhibitors of anthrax lethal factor.
    Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
    Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
    Tonello F; Montecucco C
    Mol Aspects Med; 2009 Dec; 30(6):431-8. PubMed ID: 19665472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.